Consistently, in-depth analysis of the affected genes in the significantly enriched pathways revealed that TGF-β1 and Smad3 appeared in multiple signaling pathways (Supplementary Table S2), such as cardiac hypertrophy signaling and neuroinflammation signaling pathway. This evidence concerns the gene SMAD3 and cardiac hypertrophy.